EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

VEGF in Tears as a Biomarker for Exudative Age-Related Macular Degeneration: Molecular Dynamics in a Mouse Model and Human Samples

Seyed Mohamad Mehdi Moshtaghion iD, Filippo Locri iD, Alvaro Plaza Reyes iD, Flavia Plastino, Anders Kvanta iD, Maria Jose Morillo-Sanchez, Enrique Rodríguez-de-la-Rúa, Estanislao Gutierrez-Sanchez iD, Adoración Montero-Sánchez, Helena Lucena-Padros iD, Helder André iD, Francisco J Díaz-Corrales iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083855 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Seyed Mohamad Mehdi Moshtaghion und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Pathophysiology and Therapies, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Junta de Andalucía,…. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Macular Degeneration, Tears. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III and the Fondo Europeo de Desarrollo Regional, Junta de Andalucía, Programa Nicolás Monardes, Instituto de Salud Carlos III (ISCIII).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular endothelial growth factor (VEGF) is a key mediator of exudative age-related macular degeneration (eAMD), yet non-invasive biomarkers for disease monitoring remain limited. This study evaluates VEGF levels in human tear fluid as a potential biomarker for eAMD and investigates the molecular dynamics of VEGF in a laser-induced choroidal neovascularization (lCNV) mouse model. Tear VEGF levels were quantified using proximity qPCR immunoassays in eAMD patients (n = 29) and healthy controls (n = 21) and correlated with optical coherence tomography (OCT) findings. Molecular analyses, including immunohistochemistry, gene expression profiling, and phosphorylation assays, were conducted on choroid–retinal pigment epithelium (RPE) and lacrimal gland (LG) tissues from lCNV mice (n = 25). Tear VEGF levels were significantly elevated in eAMD patients, correlating with disease severity. Females exhibited higher VEGF levels, a pattern not replicated in the mouse model. In lCNV mice, VEGF overexpression originated from the choroid–RPE, driven by hypoxic and inflammatory signaling, with no significant LG contribution. Increased VEGF, IL-6, and vimentin expression, along with NF-κB and STAT3 activation, were observed. These findings suggest that tear VEGF is a promising non-invasive biomarker for eAMD, warranting further validation for clinical application in disease monitoring and treatment optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor AMacular DegenerationTearsAnimalsHumansBiomarkersMiceFemaleDisease Models, AnimalMaleAgedRetinal Pigment EpitheliumTomography, Optical CoherenceChoroidal NeovascularizationChoroidSTAT3 Transcription FactorAged, 80 and overNF-kappa BMiddle Aged

Stichwörter der Autor:innen

age-related macular degenerationbiomarkerchoroidal neovascularizationtear fluidvascular endothelial growth factor

Substanzen

Vascular Endothelial Growth Factor ABiomarkersVEGFA protein, humanSTAT3 Transcription FactorNF-kappa B

Autor:innen und Institutionen

  • Department of Integrative Pathophysiology and Therapies, Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), Junta de Andalucía, CSIC, University of Seville, University Pablo de Olavide, 41092 Sevil…
  • Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, 17177 Stockholm, Sweden.
  • Department of Ophthalmology, Virgen Macarena University Hospital, 41009 Seville, Spain.
  • Department of Surgery, Ophthalmology Area, University of Seville, 41009 Seville, Spain.
  • Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville, CSIC, Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.

ORCID-Profile: Seyed Mohamad Mehdi Moshtaghion, Filippo Locri, Alvaro Plaza Reyes, Anders Kvanta, Estanislao Gutierrez-Sanchez, Helena Lucena-Padros, Helder André, Francisco J Díaz-Corrales

Förderung

  • Instituto de Salud Carlos III and the Fondo Europeo de Desarrollo Regional
  • Junta de Andalucía, Programa Nicolás Monardes
  • Instituto de Salud Carlos III (ISCIII)
  • European Union
  • Karolinska Institutet Foundations and Funds

Zitieren

APA

Moshtaghion, S. M. M., Locri, F., Reyes, A. P., Plastino, F., Kvanta, A., Morillo-Sanchez, M. J., Rodríguez-de-la-Rúa, E., Gutierrez-Sanchez, E., Montero-Sánchez, A., Lucena-Padros, H., André, H., & Díaz-Corrales, F. J. (2025). VEGF in Tears as a Biomarker for Exudative Age-Related Macular Degeneration: Molecular Dynamics in a Mouse Model and Human Samples. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083855

Vancouver

Moshtaghion SMM, Locri F, Reyes AP, Plastino F, Kvanta A, Morillo-Sanchez MJ, et al. VEGF in Tears as a Biomarker for Exudative Age-Related Macular Degeneration: Molecular Dynamics in a Mouse Model and Human Samples. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083855

BibTeX
@article{Moshtaghion2025,
  author = {Moshtaghion, Seyed Mohamad Mehdi and Locri, Filippo and Reyes, Alvaro Plaza and Plastino, Flavia and Kvanta, Anders and Morillo-Sanchez, Maria Jose and Rodríguez-de-la-Rúa, Enrique and Gutierrez-Sanchez, Estanislao and Montero-Sánchez, Adoración and Lucena-Padros, Helena and André, Helder and Díaz-Corrales, Francisco J},
  title = {VEGF in Tears as a Biomarker for Exudative Age-Related Macular Degeneration: Molecular Dynamics in a Mouse Model and Human Samples},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083855}
}
Kostenlos starten →